EICHERMOT-NS

EICHERMOT-NS

EICHERMOT-NS

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2024 Q3	Sep 30, 2024	ITUS Capital	-	-	ABB.NS, AUROPHARMA.NS, BAJAJ-AUTO.NS, BHARATFORG.NS, BLUESTARCO.NS, DRREDDY.NS, EICHERMOT.NS, GAIL.NS, HAVELLS.NS, ICICIGI.NS, IEX.NS, IPCALAB.NS, ITC.NS, MARICO.NS, MARUTI.NS, NTPC.NS, PETRONET.NS, POWERGRID.NS, RELIANCE.NS, SBILIFE.NS	Autos, earnings, India, large cap, liquidity, Pharmaceuticals, Power, Rural	Strong earnings growth driven by domestic fundamentals with portfolio companies showing 30.6% EPS growth year-over-year. Structural improvement in RoEs for top 500 companies in India over the last 4 years has resulted in strong market performance. Focus on companies where earnings growth is accompanied by RoE expansion.		View
2024 Q2	Jul 30, 2024	Artemis Global Select Fund	0.5%	-	7911.T, 7958.T, AAL.L, CPRI.MI, DG.PA, EICHERMOT.NS, EL, FUJIFILM, GFNORTEO.MX, HDB, ICE, META, MTX.DE, MUFG, NKE, RIO, RVTY, RYAAY, TCOM, TMO, TSM	AI, China, consumer, global, healthcare, India, semiconductors, technology	The fund benefited from strong returns across semiconductor holdings as the generative AI demand boom feeds through to the supporting hardware supply chain. Taiwan Semiconductor Manufacturing Company saw meaningful sales and profit growth as clients attempt to meet surging demand for AI chips.	GFNORTEO.MX RYA.L EL EICHERMOT.NS HDB TSM	View
2025 Q2	Jun 30, 2025	ITUS Capital	-	-	AUROBINDO.NS, BAJAJ-AUTO.NS, CUB.NS, DRREDDY.NS, EICHERMOT.NS, GILLETTE.NS, HDFCAMC.NS, HDFCBANK.NS, HINDUSTANCOPPER.NS, HINDZINC.NS, ICICIBANK.NS, IGI.NS, INTERGLOBE.NS, ITC.NS, MARICO.NS, PBFINTECH.NS, PIRAMALP.NS, TITAN.NS, TVSMOTOR.NS, VEDL.NS	Banking, earnings, India, infrastructure, Pharmaceuticals, tariffs, Valuations	US tariff policies are creating global trade volatility and uncertainty. The manager discusses how tariffs protect domestic industries at the expense of consumers and global welfare, while potentially increasing inflation and devaluing currency. This uncertain environment requires global allocators to rethink their marginal dollar allocation.		View
2024 Q2	Jun 30, 2024	2Point2 Capital	-	-	BAJFINANCE.NS, EICHERMOT.NS, HINDPETRO.NS	Base Rate, Behavioral Finance, India, Market Multiples, Valuations, Value Investing	Indian stock market valuations have reached absurd levels never before seen in capital market history. Small and mid-cap valuations are particularly extreme, with 217 stocks trading above 75x TTM P/E and 392 above 50x TTM P/E among top 1000 companies. Base rate analysis shows very few companies can deliver the high growth rates needed to justify these valuations.		View
2025 Q1	Mar 31, 2025	ITUS Capital	-	-	ABB.NS, AUROPHARMA.NS, BAJAJ-AUTO.NS, DRREDDY.NS, EICHERMOT.NS, GILLETTE.NS, HAVELLS.NS, HDFCAMC.NS, HDFCBANK.NS, HINDCOPPER.NS, ICICIBANK.NS, ICICIGI.NS, ITC.NS, MARICO.NS, PBFINTECH.NS, PIRAMALP.NS, TITAN.NS, TVSMOTOR.NS, ULTRACEMCO.NS, VEDL.NS	banks, consumer, Government Spending, India, large cap, Pharmaceuticals, tariffs, valuation	Portfolio is overweight banks with focus on market leaders like ICICI Bank and HDFC Bank. Manager expects bottoms-up outlook on lending growth and views banks as offering better risk-reward at current valuations.		View
2024 Q4	Dec 31, 2024	ITUS Capital	-	-	AMBUJACEM.NS, AUROPHARMA.NS, BAJAJ-AUTO.NS, DRREDDY.NS, EICHERMOT.NS, GAIL.NS, HAVELLS.NS, HDFCAMC.NS, HDFCBANK.NS, ICICIBANK.NS, IEX.NS, ITC.NS, KEI.NS, LT.NS, MARICO.NS, PBFINTECH.NS, PIRAMALP.NS, POWERGRID.NS, RELIANCE.NS, TVSMOTOR.NS	Capex, Copper, Domestic Flows, healthcare, India, infrastructure, technology, Two Wheelers	Healthcare continues to be the largest exposure across portfolios with strong growth outlook benefiting from low-cost manufacturing and lower price erosion in US pharma. The manager expects CY25 to be a strong growth sector for pharma which is reflected across portfolio positioning.	ICICIGI.NS KEIIND.NS	View
2025 Q4	Jan 7, 2026	ITUS Capital	0.0%	6.6%	CUB.NS, DRREDDY.NS, EICHERMOT.NS, ERIS.NS, HDFCAMC.NS, HDFCBANK.NS, HDFCLIFE.NS, HINDCOPPER.NS, HINDZINC.NS, ICICIBANK.NS, ICICIGI.NS, NAVINFLUOR.NS, PAYTM.NS, PBFINTECH.NS, PIRAMALP.NS, SBIN.NS, SRF.NS, SWIGGY.NS, TITAN.NS, VEDL.NS	Bottom Up, earnings, growth, healthcare, India, Mining, Multi Cap, selectivity	The fund maintains an overweight position in mining and metals, driven by rising demand for copper in manufacturing and batteries. Performance was largely driven by strong stock selection within the sector, though they remain cautious on incremental additions at current valuations above long-term averages. Despite a challenging year due to tariff-related concerns and adverse headlines from the US, many healthcare businesses continue to invest meaningfully in their core franchises and R&D capabilities. The fund's exposure is aligned toward companies where earnings quality and long-term visibility remain intact. The fund's exposure spans banks, NBFCs, and select non-lending financial institutions. They remain opportunistic in adding risk selectively, guided by valuation discipline and balance sheet strength, with a bottoms-up outlook on lending growth. The fund's consumer exposure is less focused on brands and more on businesses that control distribution channels. They believe this segment has potential to drive incremental growth as consumption normalizes and pricing power becomes more relevant.		View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
Apr 13, 2026	Fund Letters	Artemis Global Select Fund	Eicher Motors	Consumer Discretionary	Automobile Manufacturers	Bull	NSE	Consumer Discretionary, India, market share, Motorcycles, premium, Royal Enfield, Volume Recovery	View Pitch

BSD Shareholders of EICHERMOT-NS

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: